Loading...
Long-Term Outcome After Liver Transplantation for Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment
BACKGROUND: Bridging treatments are employed in liver transplant waitlist patients with hepatocellular carcinoma (HCC) because of the risk of tumor progression during the waiting time. Radioembolization is mostly employed in the control of large or multifocal HCCs when other locoregional treatment m...
Saved in:
| Published in: | Ann Transplant |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
International Scientific Literature, Inc.
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6248013/ https://ncbi.nlm.nih.gov/pubmed/28408731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AOT.902595 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|